These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28866269)

  • 1. Discovery of a novel, CNS penetrant M
    Bewley BR; Spearing PK; Weiner RL; Luscombe VB; Zhan X; Chang S; Cho HP; Rodriguez AL; Niswender CM; Conn PJ; Bridges TM; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4274-4279. PubMed ID: 28866269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core.
    Wood MR; Noetzel MJ; Engers JL; Bollinger KA; Melancon BJ; Tarr JC; Han C; West M; Gregro AR; Lamsal A; Chang S; Ajmera S; Smith E; Chase P; Hodder PS; Bubser M; Jones CK; Hopkins CR; Emmitte KA; Niswender CM; Wood MW; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3029-3033. PubMed ID: 27185330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of structurally distinct tricyclic M
    Long MF; Capstick RA; Spearing PK; Engers JL; Gregro AR; Bollinger SR; Chang S; Luscombe VB; Rodriguez AL; Cho HP; Niswender CM; Bridges TM; Conn PJ; Lindsley CW; Engers DW; Temple KJ
    Bioorg Med Chem Lett; 2021 Dec; 53():128416. PubMed ID: 34710625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists.
    Bender AM; Weiner RL; Luscombe VB; Ajmera S; Cho HP; Chang S; Zhan X; Rodriguez AL; Niswender CM; Engers DW; Bridges TM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3576-3581. PubMed ID: 28633897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the development of an M
    Tarr JC; Wood MR; Noetzel MJ; Bertron JL; Weiner RL; Rodriguez AL; Lamsal A; Byers FW; Chang S; Cho HP; Jones CK; Niswender CM; Wood MW; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2990-2995. PubMed ID: 28522253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition.
    Wood MR; Noetzel MJ; Tarr JC; Rodriguez AL; Lamsal A; Chang S; Foster JJ; Smith E; Chase P; Hodder PS; Engers DW; Niswender CM; Brandon NJ; Wood MW; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4282-6. PubMed ID: 27476142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M
    Chopko TC; Han C; Gregro AR; Engers DW; Felts AS; Poslusney MS; Bollinger KA; Morrison RD; Bubser M; Lamsal A; Luscombe VB; Cho HP; Schnetz-Boutaud NC; Rodriguez AL; Chang S; Daniels JS; Stec DF; Niswender CM; Jones CK; Wood MR; Wood MW; Duggan ME; Brandon NJ; Conn PJ; Bridges TM; Lindsley CW; Melancon BJ
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2224-2228. PubMed ID: 31248774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M
    Long MF; Engers JL; Chang S; Zhan X; Weiner RL; Luscombe VB; Rodriguez AL; Cho HP; Niswender CM; Bridges TM; Conn PJ; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2017 Nov; 27(22):4999-5001. PubMed ID: 29037946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of 4,6-disubstituted pyrimidines as CNS penetrant pan-muscarinic antagonists with a novel chemotype.
    Bender AM; Weiner RL; Luscombe VB; Cho HP; Niswender CM; Engers DW; Bridges TM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2479-2483. PubMed ID: 28427812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel 3,4-dimethylcinnoline carboxamide M
    Temple KJ; Engers JL; Long MF; Gregro AR; Watson KJ; Chang S; Jenkins MT; Luscombe VB; Rodriguez AL; Niswender CM; Bridges TM; Conn PJ; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2019 Nov; 29(21):126678. PubMed ID: 31537424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M
    Temple KJ; Engers JL; Long MF; Watson KJ; Chang S; Luscombe VB; Jenkins MT; Rodriguez AL; Niswender CM; Bridges TM; Conn PJ; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126812. PubMed ID: 31784320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Optimization of Potent and CNS Penetrant M
    Bender AM; Cho HP; Nance KD; Lingenfelter KS; Luscombe VB; Gentry PR; Voigtritter K; Berizzi AE; Sexton PM; Langmead CJ; Christopoulos A; Locuson CW; Bridges TM; Chang S; O'Neill JC; Zhan X; Niswender CM; Jones CK; Conn PJ; Lindsley CW
    ACS Chem Neurosci; 2018 Jul; 9(7):1572-1581. PubMed ID: 29678111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration.
    Panarese JD; Cho HP; Adams JJ; Nance KD; Garcia-Barrantes PM; Chang S; Morrison RD; Blobaum AL; Niswender CM; Stauffer SR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3822-5. PubMed ID: 27173801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-exploration of the mGlu₁ PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SAR.
    Garcia-Barrantes PM; Cho HP; Starr TM; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 May; 26(9):2289-92. PubMed ID: 27013388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the development of an M
    Wood MR; Noetzel MJ; Poslusney MS; Melancon BJ; Tarr JC; Lamsal A; Chang S; Luscombe VB; Weiner RL; Cho HP; Bubser M; Jones CK; Niswender CM; Wood MW; Engers DW; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2017 Jan; 27(2):171-175. PubMed ID: 27939174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of structurally distinct tricyclic M
    Temple KJ; Long MF; Engers JL; Watson KJ; Chang S; Luscombe VB; Rodriguez AL; Niswender CM; Bridges TM; Conn PJ; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126811. PubMed ID: 31787491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery, Optimization, and Biological Characterization of 2,3,6-Trisubstituted Pyridine-Containing M
    Schubert JW; Harrison ST; Mulhearn J; Gomez R; Tynebor R; Jones K; Bunda J; Hanney B; Wai JM; Cox C; McCauley JA; Sanders JM; Magliaro B; O'Brien J; Pajkovic N; Huszar Agrapides SL; Taylor A; Gotter A; Smith SM; Uslaner J; Browne S; Risso S; Egbertson M
    ChemMedChem; 2019 May; 14(9):943-951. PubMed ID: 30920765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.
    Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3189-93. PubMed ID: 24856064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel M
    Poslusney MS; Salovich JM; Wood MR; Melancon BJ; Bollinger KA; Luscombe VB; Rodriguez AL; Engers DW; Bridges TM; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2019 Feb; 29(3):362-366. PubMed ID: 30580918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M(4) muscarinic acetylcholine receptor agonists.
    Suwa A; Konishi Y; Uruno Y; Takai K; Nakako T; Sakai M; Enomoto T; Ochi Y; Matsuda H; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2909-12. PubMed ID: 24852118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.